Tarsadia Strengthens Venture, Growth & Private Investing Practice with New Sector Heads

Unique Platform Bolsters Expertise with Rikhil Bajaj in Financial Technology &
Software and Dr. Shubhra Jain in Healthcare Technology

Business Wire

NEW YORK — September 19, 2023

Tarsadia Investments, a multibillion-dollar firm that makes high-conviction
investments in category-defining companies globally, is proud to announce the
expansion of its Venture, Growth & Private Investing (“VGP”) practice with the
addition of two industry experts. These accomplished professionals bring
invaluable expertise in financial technology, software, and healthcare to the
firm, reinforcing Tarsadia’s commitment to driving transformative change in
these industries.

Sponsored by a permanent capital base, Tarsadia offers entrepreneurs maximum
alignment, often partnering over a decade-plus investment horizon. Tarsadia
combines deep thematic research with decades of operating experience to make
high-conviction investments across multiple stages. Tarsadia’s
multi-disciplinary and collaborative approach across venture, private equity,
and public markets drives unique insight and support for founders across the
business life cycle. Additionally, the firm’s flexible mandate enables
creative deal structures, including financing growth, recapitalizations, or
acquisitions of significant competitors.

Rikhil Bajaj leads the firm’s VGP investments in financial technology,
software, and digital assets. Informed by his experience working with growth
stage to scale businesses, Rikhil supports entrepreneurs on topics including
growth, talent, and financing/M&A. Prior to Tarsadia, Rikhil was a founding
member of the growth equity team at SignalFire, a $1.5B+ venture fund, and
part of the senior team at GTCR, a $20B+ private equity firm. Rikhil also
worked as a technology and healthcare investor at Warburg Pincus and Primus
Capital. Rikhil holds an MBA from The Wharton School at the University of
Pennsylvania and a BBA (Honors) from the Schulich School of Business, York

Dr. Shubhra Jain leads the firm’s VGP investments in healthcare technology,
leveraging her experience as a physician and tech acumen to support founders
in building a more equitable, affordable, and effective healthcare ecosystem.
Prior to Tarsadia, Dr. Jain built and led a healthcare investment practice at
Cota Capital, where she invested in businesses like Berkeley Lights, Zymergen,
and Mission Bio. She also has operating experience leading product development
and launch at a health-tech startup. Dr. Jain is a primary care physician by
background. She also has her M.S. in Engineering from Stanford School of
Engineering and her MBA from The Wharton School.

“We are constantly evolving and elevating our team to augment our
founder-first DNA,” said Rishi Reddy, Managing Director and Head of the VGP
practice at Tarsadia Investments. “We are excited to welcome Rikhil Bajaj and
Dr. Shubhra Jain to our team. Their investment experience and sector expertise
will play a crucial role in our mission to support visionary founders and
drive transformative change in these industries.”

About Tarsadia Investments, LLC

Tarsadia Investments is a multibillion-dollar private investment management
vehicle that makes high-conviction investments in category-defining companies
globally. We are a supportive and value-enhancing investment partner and have
a history of seeking out and working with exceptional management teams. We’ve
invested across stages from idea to public ownership, with often a decade-plus
investment horizon. We use our domain expertise in financial services,
healthcare, real estate, and technology to support founders on growth, talent,
and M&A and capital raising.

View source version on businesswire.com:


Jacqueline Silva
[email protected]

We’d love to hear from you

Let’s work together and make great things happen.

Get in touch

Sign up for our newsletter

© All rights reserved Tarsadia